News Digest / StockInvest.us

Author: StockInvest.us

05:03pm, Thursday, May 01, 2025
Travere Therapeutics, Inc. (NASDAQ: TVTX) has reported significant developments in its financial position and product offerings for the first quarter of 2025. Here’s a concise breakdown of key metrics and insights into the company's operations. Key Financial Highlights: Net product sales: $75.9 ...